The KM analysis, along with the typical IHC staining of SLIT3, TNN, IGHD, and KRRB1, showed that the expression was significantly different between normal and breast cancer tissues and confirmed the prognostic effect of the TME risk signature. The gene discussed is SLIT3; the disease is breast carcinoma.